“CemiplimAb-Rwlc Survivorship and Epidemiology (CASE): A Prospective Study of the Safety and Efficacy of Cemiplimab in Patients With Advanced Cutaneous Squamous Cell Carcinoma (CSCC) in a Real-World Setting”. SKIN The Journal of Cutaneous Medicine 7, no. 2 (March 13, 2023): s174. Accessed March 9, 2026. https://skin.dermsquared.com/skin/article/view/1998.